|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
40,510,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0 - $0 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile SI-BONE is a medical device company. Co. has a proprietary minimally invasive surgical implant system, which it calls iFuse, to address sacroiliac joint dysfunction and degeneration, adult deformity, pelvic ring traumatic fractures. Co.'s iFuse Implant System includes a series of patented triangular implants and the instruments Co. has developed to enable surgeons to perform the procedures using different surgical approaches for different indications. Co. has introduced iFuse-3D, its other implant. This patented titanium implant combines the triangular cross-section of the iFuse Classic implant with the proprietary 3D-printed porous surface and a fenestrated design.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
22,856 |
94,402 |
236,472 |
666,595 |
Total Sell Value |
$355,754 |
$1,854,443 |
$4,826,798 |
$13,818,404 |
Total People Sold |
4 |
6 |
7 |
8 |
Total Sell Transactions |
10 |
18 |
37 |
75 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Yerby Scott A |
Chief Technology Officer |
|
2019-08-20 |
4 |
AS |
$20.01 |
$89,292 |
I/I |
(4,462) |
106,853 |
|
- |
|
Recupero Anthony J |
Chief Commercial Officer |
|
2019-08-16 |
4 |
AS |
$20.00 |
$6,000 |
D/D |
(300) |
18,854 |
|
- |
|
Recupero Anthony J |
Chief Commercial Officer |
|
2019-08-16 |
4 |
OE |
$4.32 |
$1,296 |
D/D |
300 |
19,154 |
|
- |
|
Reckling W Carlton |
CMO and VP, Medical Affairs |
|
2019-08-16 |
4 |
AS |
$20.00 |
$6,000 |
D/D |
(300) |
9,896 |
|
- |
|
Reckling W Carlton |
CMO and VP, Medical Affairs |
|
2019-08-16 |
4 |
OE |
$3.96 |
$1,188 |
D/D |
300 |
10,196 |
|
- |
|
Dunn Jeffrey W |
Chairman, President & CEO |
|
2019-08-16 |
4 |
AS |
$19.64 |
$785,740 |
I/I |
(40,000) |
507,540 |
|
- |
|
Yerby Scott A |
Chief Technology Officer |
|
2019-08-16 |
4 |
AS |
$20.00 |
$8,000 |
I/I |
(400) |
111,315 |
|
- |
|
Yerby Scott A |
Chief Technology Officer |
|
2019-08-15 |
4 |
AS |
$18.39 |
$186,382 |
I/I |
(10,133) |
111,715 |
|
- |
|
Skyline Venture Management V, Llc |
|
|
2019-08-12 |
4 |
S |
$18.25 |
$7,300,000 |
I/I |
(400,000) |
4,019,985 |
|
- |
|
Freund John Gordon |
|
|
2019-08-12 |
4 |
S |
$18.25 |
$7,300,000 |
I/I |
(400,000) |
4,019,985 |
|
- |
|
Yerby Scott A |
Chief Technology Officer |
|
2019-08-06 |
4 |
AS |
$17.07 |
$11,078 |
I/I |
(649) |
121,848 |
|
- |
|
Yerby Scott A |
Chief Technology Officer |
|
2019-08-02 |
4 |
AS |
$17.81 |
$6,697 |
D/D |
(376) |
9,391 |
|
- |
|
Recupero Anthony J |
Chief Commercial Officer |
|
2019-08-01 |
4 |
AS |
$18.11 |
$21,731 |
D/D |
(1,200) |
18,854 |
|
- |
|
Recupero Anthony J |
Chief Commercial Officer |
|
2019-08-01 |
4 |
OE |
$4.32 |
$5,184 |
D/D |
1,200 |
20,054 |
|
- |
|
Francis Laura |
Chief Financial Officer |
|
2019-07-25 |
4 |
AS |
$19.34 |
$48,708 |
D/D |
(2,518) |
90,039 |
|
- |
|
Francis Laura |
Chief Financial Officer |
|
2019-07-25 |
4 |
OE |
$4.32 |
$10,878 |
D/D |
2,518 |
92,557 |
|
- |
|
Francis Laura |
Chief Financial Officer |
|
2019-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
90,039 |
|
- |
|
Dunn Jeffrey W |
Chairman, President & CEO |
|
2019-07-18 |
4 |
S |
$20.16 |
$28,948 |
D/D |
(1,436) |
99,997 |
|
- |
|
Yerby Scott A |
Chief Technology Officer |
|
2019-07-18 |
4 |
AS |
$20.01 |
$200,147 |
I/I |
(10,000) |
122,873 |
|
- |
|
Yerby Scott A |
Chief Technology Officer |
|
2019-07-18 |
4 |
AS |
$20.00 |
$4,340 |
D/D |
(217) |
9,767 |
|
- |
|
Reckling W Carlton |
CMO and VP, Medical Affairs |
|
2019-07-18 |
4 |
AS |
$20.00 |
$3,060 |
D/D |
(153) |
9,896 |
|
- |
|
Pisetsky Michael A |
GC & Chief Compliance Officer |
|
2019-07-18 |
4 |
S |
$20.00 |
$4,840 |
D/D |
(242) |
17,831 |
|
- |
|
Recupero Anthony J |
Chief Commercial Officer |
|
2019-07-18 |
4 |
S |
$20.00 |
$8,380 |
D/D |
(419) |
18,854 |
|
- |
|
Francis Laura |
Chief Financial Officer |
|
2019-07-18 |
4 |
S |
$20.00 |
$9,700 |
D/D |
(485) |
70,039 |
|
- |
|
Reckling W Carlton |
CMO and VP, Medical Affairs |
|
2019-07-17 |
4 |
AS |
$20.01 |
$100,058 |
D/D |
(5,000) |
10,049 |
|
- |
|
440 Records found
|
|
Page 15 of 18 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|